Diagnosis of hemochromatosis

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 925-931

  Powell, Lawrie W ^a   George, D Keith ^a   McDonnell, Sharon M ^a   Kowdley, Kris V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER CIRRHOSIS; PHLEBOTOMY; PRIORITY JOURNAL; SCREENING;

EID: 0032403101     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00002     Document Type: Article

References (41)

1. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. Philadelphia: WB Saunders; 1994:227-70.
2. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med. 1998;129:946-53.
3. Barton JC, Barton NH, Alford TJ. Diagnosis of hemochromatosis probands in a community hospital. Am J Med. 1997;103:498-503.
4. Von Recklinghhausen FD. Uber Haemochromatose. Heidelberg: Taggeblatt (62) Versammling Dtsch Naturforsch Artze; 1889:324-5.
5. Sheldon JH. Haemochromatosis. London: Oxford Univ Pr; 1935.
6. MacDonald RA. Primary haemochromatosis: inherited or acquired? Progress in Haematology. 1966;5:324-53.
7. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut. 1976;2:332-4.
8. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy A, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;134:399-408.
9. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al. Haemochromatosis and HLA-H [Letter]. Nat Genet. 1996;14:249-51.
10. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 1997;60:828-32.
11. Burke W, Thomson E, Khoury MJ, McDonell SM, Press N, Adams PC, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998;280:172-8.
12. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. Medicine (Baltimore). 1955;34:381-430.
13. MacDonald RA. Hemochromatosis cirrhosis in different geographic areas. Am J Med Sci. 1965;249:36-46.
14. MacSween RN, Scott AR. Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol. 1973;26:936-42.
15. Legett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol. 1990;74:525-30.
16. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
17. Wiggers P, Dalhoj J, Kiaer H, Ring-Larsen H, Petersen PH, Blaabjerg O, et al. Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med. 1991;230:265-70.
18. Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil N, Maurer M, et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med. 1998;128: 337-45.
19. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology. 1998;114:1003-8.
20. Kushner JP. Screening for hemochromatosis [Editorial]. Gastroenterology. 1995;109:315-6.
21. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology. 1995;109:177-88.
22. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
23. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW. Expression of hemochromatosis in homozygous subjects. Implications for early diaqnosis and prevention. Gastroenterology. 1990;98:1625-32.
24. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
25. Conte D, Manachino D, Colli A, Guala A, Aimo G, Andreoletti M, et al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med. 1998;128:370-3.
26. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-19.
27. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen. 1996;3:178-84.
28. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med. 1996;335:1799-805.
29. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology. 1997;25:162-6.
30. Lloyd HM, Powell LW, Thomas MJ. Idiopathic haemochromatosis in menstruating women. Lancet. 1964;2:555-6.
31. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 1997;127:105-10.
32. George DK, Evans RM, Crofton RW, Gunn IR. Testing for haemochromaosis in the diabetic clinic. Ann Clin Biochem. 1995;32:521-6.
33. Olynyk J, Hall P, Ahern M, Kwiatek R, Mackinnon M. Screening tor genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med. 1994; 24:22-5.
34. McLaren CE, McLachlan GJ, Halliday JW, Webb SI, Leggett BA, Jazwinska EC, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology. 1998;114:543-9.
35. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Ann Intern Med. 1998;128: 932-9.
36. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 1997;349:95-7.
37. Kowdley KV, Trainer TD, Saltzman JR, Pedrosa M, Krawitt EL, Knox TA, et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology. 1997;113:1270-7.
38. Powell LW. Hemochromatosis: the impact of early diagnosis and therapy [Editorial]. Gastroenterology. 1996;110:1304-7.
39. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 1986;6:24-9.
40. Rubin RB, Barton AL, Banner BF, Bonkovsky HL. Iron and chronic viral hepatitis: emerging evidence for an important interaction. Dig Dis. 1995;13: 223-38.
41. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology. 1990;12:20-5.